• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测大唾液腺癌患者长期总生存和癌症特异性生存的列线图:一项基于人群的研究

Nomograms for predicting long-term overall survival and cancer-specific survival in patients with major salivary gland cancer: a population-based study.

作者信息

Li Yun, Ju Jun, Liu Xiaoxiao, Gao Tao, Wang Zhidong, Ni Qianwei, Ma Chao, Zhao Zhenyan, Ren Yixiong, Sun Moyi

机构信息

State Key Laboratory of Military Stomatology, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, Fourth Military Medical University, Xi'an, China.

Department of Otolaryngology Head and Neck Surgery, Navy General Hospital, Beijing, China.

出版信息

Oncotarget. 2017 Apr 11;8(15):24469-24482. doi: 10.18632/oncotarget.14905.

DOI:10.18632/oncotarget.14905
PMID:28160551
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5421863/
Abstract

In this study, we aimed to develop and validate nomograms for predicting long-term overall survival (OS) and cancer-specific survival (CSS) in major salivary gland cancer (MSGC) patients. These nomograms were developed using a retrospective cohort (N=4218) from the Surveillance, Epidemiology, and End Results (SEER) database, and externally validated using an independent data cohort (N=244). We used univariate, and multivariate analyses, and cumulative incidence function to select the independent prognostic factors of OS and CSS. Index of concordance (c-index) and calibration plots were used to estimate the nomograms' predictive accuracy. The median follow-up period was 34 months (1-119 months). Of 4218 MSGC patients, 1320 (31.3%) died by the end of the follow-up; of these 1320 patients, 883 (20.9%) died of MSGC. The OS nomogram, which had a c-index of 0.817, was based on nine variables: age, sex, tumor site, tumor grade, surgery performed, radiation therapy and TNM classifications. The CSS nomogram, which had a c-index of 0.829, was based on the same nine variables plus race. External validation c-indexes were 0.829 and 0.807 for OS and CSS, respectively. Based on SEER database, we have developed nomograms predicting five- and eight-years OS and CSS for MSGC patients with perfect accuracy. These nomograms will help clinicians customize treatment and monitoring strategies in MSGC patients.

摘要

在本研究中,我们旨在开发并验证用于预测大唾液腺癌(MSGC)患者长期总生存期(OS)和癌症特异性生存期(CSS)的列线图。这些列线图是使用来自监测、流行病学和最终结果(SEER)数据库的回顾性队列(N = 4218)开发的,并使用独立数据队列(N = 244)进行外部验证。我们使用单变量和多变量分析以及累积发病率函数来选择OS和CSS的独立预后因素。一致性指数(c指数)和校准图用于估计列线图的预测准确性。中位随访期为34个月(1 - 119个月)。在4218例MSGC患者中,1320例(31.3%)在随访结束时死亡;在这1320例患者中,883例(20.9%)死于MSGC。OS列线图的c指数为0.817,基于九个变量:年龄、性别、肿瘤部位、肿瘤分级、所进行的手术、放射治疗和TNM分类。CSS列线图的c指数为0.829,基于相同的九个变量加上种族。OS和CSS的外部验证c指数分别为0.829和0.807。基于SEER数据库,我们开发了列线图,可完美准确地预测MSGC患者的5年和8年OS及CSS。这些列线图将有助于临床医生为MSGC患者定制治疗和监测策略。

相似文献

1
Nomograms for predicting long-term overall survival and cancer-specific survival in patients with major salivary gland cancer: a population-based study.预测大唾液腺癌患者长期总生存和癌症特异性生存的列线图:一项基于人群的研究
Oncotarget. 2017 Apr 11;8(15):24469-24482. doi: 10.18632/oncotarget.14905.
2
Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.预测头颈部鳞状细胞癌患者长期总生存率和癌症特异性生存率的列线图。
Oncotarget. 2016 Aug 9;7(32):51059-51068. doi: 10.18632/oncotarget.10595.
3
Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands.术后列线图预测主要涎腺恶性肿瘤手术治疗后的生存情况。
Ann Surg Oncol. 2014 Feb;21(2):637-42. doi: 10.1245/s10434-013-3321-y. Epub 2013 Oct 17.
4
Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours.开发和验证用于预测胃肠道间质瘤患者生存的列线图。
Eur J Surg Oncol. 2018 Oct;44(10):1657-1665. doi: 10.1016/j.ejso.2018.07.004. Epub 2018 Jul 20.
5
Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.预测小唾液腺癌:一种用于总生存和癌症特异性生存的新的列线图和风险分类系统。
Otolaryngol Head Neck Surg. 2021 Feb;164(2):359-368. doi: 10.1177/0194599820938323. Epub 2020 Jul 21.
6
Applying nomograms based on the surveillance, epidemiology and end results database to predict long-term overall survival and cancer-specific survival in patients with oropharyngeal squamous cell carcinomas: A case-control research.应用基于监测、流行病学和最终结果数据库的列线图预测口咽鳞状细胞癌患者的长期总生存和癌症特异性生存:一项病例对照研究。
Medicine (Baltimore). 2020 Jul 24;99(30):e20703. doi: 10.1097/MD.0000000000020703.
7
Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?列线图能否预测软骨肉瘤患者的总生存和癌症特异性生存?
Clin Orthop Relat Res. 2018 May;476(5):987-996. doi: 10.1007/s11999.0000000000000152.
8
Nomograms to predict survival after colorectal cancer resection without preoperative therapy.预测未经术前治疗的结直肠癌切除术后生存率的列线图。
BMC Cancer. 2016 Aug 19;16(1):658. doi: 10.1186/s12885-016-2684-4.
9
Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients with Major Salivary Gland Mucoepidermoid Carcinoma.预测大唾液腺黏液表皮样癌患者总生存期和癌症特异性生存期的预后列线图
J Cancer. 2019 Jul 22;10(18):4380-4388. doi: 10.7150/jca.27992. eCollection 2019.
10
Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.用于预测肾癌患者总生存期和癌症特异性生存期的预后列线图及Aggtrmmns评分系统。 需注意,原文中的“Aggtrmmns”可能有误,不太明确其准确含义。
Cancer Med. 2020 Apr;9(8):2710-2722. doi: 10.1002/cam4.2916. Epub 2020 Feb 22.

引用本文的文献

1
Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma.经导管动脉化疗栓塞术治疗肝细胞癌后栓塞后综合征预测列线图的构建。
Sci Rep. 2024 Feb 8;14(1):3303. doi: 10.1038/s41598-024-53711-y.
2
Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma.制定并验证列线图预测骨肉瘤患者长期癌症特异性生存的模型。
Sci Rep. 2023 Jun 23;13(1):10230. doi: 10.1038/s41598-023-37391-8.
3
Development of a predictive model to identify patients most likely to benefit from surgery in metastatic breast cancer.

本文引用的文献

1
Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.预测头颈部鳞状细胞癌患者长期总生存率和癌症特异性生存率的列线图。
Oncotarget. 2016 Aug 9;7(32):51059-51068. doi: 10.18632/oncotarget.10595.
2
Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.用于评估腔面型乳腺癌患者长期总生存率和乳腺癌特异性生存率的列线图。
Oncotarget. 2016 Apr 12;7(15):20496-506. doi: 10.18632/oncotarget.7975.
3
A predictive nomogram improved diagnostic accuracy and interobserver agreement of perirectal lymph nodes metastases in rectal cancer.
开发一种预测模型,以确定转移性乳腺癌中最有可能从手术中获益的患者。
Sci Rep. 2023 Mar 8;13(1):3845. doi: 10.1038/s41598-023-30793-8.
4
Construction and validation of a prognostic nomogram in metastatic breast cancer patients of childbearing age: A study based on the SEER database and a Chinese cohort.育龄期转移性乳腺癌患者预后列线图的构建与验证:一项基于监测、流行病学和最终结果(SEER)数据库及中国队列的研究
Front Oncol. 2022 Nov 25;12:999873. doi: 10.3389/fonc.2022.999873. eCollection 2022.
5
A Visualized Dynamic Prediction Model for Overall Survival in Elderly Patients With Pancreatic Cancer for Smart Medical Services.用于智能医疗服务的老年胰腺癌患者总生存期可视化动态预测模型。
Front Public Health. 2022 May 24;10:885624. doi: 10.3389/fpubh.2022.885624. eCollection 2022.
6
Development of a prognostic nomogram for metastatic pancreatic ductal adenocarcinoma integrating marital status.基于婚姻状况构建用于预测转移性胰腺导管腺癌的列线图
Sci Rep. 2022 May 3;12(1):7124. doi: 10.1038/s41598-022-11318-1.
7
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).吉西他滨联合白蛋白紫杉醇或 FOLFIRINOX 治疗不可切除胰腺癌患者的预后列线图:日本多中心回顾性研究(NAPOLEON 研究)的事后分析。
BMC Cancer. 2022 Jan 3;22(1):19. doi: 10.1186/s12885-021-09139-y.
8
Prediction of Recurrence by Machine Learning in Salivary Gland Cancer Patients After Adjuvant (Chemo)Radiotherapy.机器学习预测涎腺癌患者辅助(放)化疗后复发
In Vivo. 2021 Nov-Dec;35(6):3355-3360. doi: 10.21873/invivo.12633.
9
Nomograms-based prediction of overall and cancer-specific survivals for patients diagnosed with major salivary gland carcinoma.基于列线图对确诊为大唾液腺癌患者的总生存期和癌症特异性生存期的预测
Ann Transl Med. 2021 Aug;9(15):1230. doi: 10.21037/atm-21-1725.
10
A Simple-to-Use Nomogram for Predicting Survival in Children with Acute Myeloid Leukemia.用于预测急性髓系白血病儿童生存情况的简单易用列线图。
Biomed Res Int. 2021 Mar 11;2021:7264623. doi: 10.1155/2021/7264623. eCollection 2021.
一种预测性列线图提高了直肠癌直肠周围淋巴结转移的诊断准确性和观察者间一致性。
Oncotarget. 2016 Mar 22;7(12):14755-64. doi: 10.18632/oncotarget.7548.
4
Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.预测腺样囊性癌患者生存和复发的列线图。一项国际合作研究。
Eur J Cancer. 2015 Dec;51(18):2768-76. doi: 10.1016/j.ejca.2015.09.004. Epub 2015 Nov 19.
5
Head and Neck Cancers, Version 1.2015.《头颈癌,2015年第1版》
J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856. doi: 10.6004/jnccn.2015.0102.
6
Outcomes and prognostic factors in modern era management of major salivary gland cancer.现代主要涎腺癌治疗的结局与预后因素
Oral Oncol. 2015 Aug;51(8):770-7. doi: 10.1016/j.oraloncology.2015.05.005. Epub 2015 May 29.
7
Cancers of major salivary glands.大唾液腺肿瘤
Surg Oncol Clin N Am. 2015 Jul;24(3):615-33. doi: 10.1016/j.soc.2015.03.011.
8
Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients.列线图预测鼻咽癌患者放疗反应和总生存的建立和外部验证。
Eur J Cancer. 2015 Jul;51(10):1303-11. doi: 10.1016/j.ejca.2015.04.003. Epub 2015 Apr 28.
9
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib.伊马替尼治疗转移性胃肠道间质瘤的预后列线图的开发与验证
Eur J Cancer. 2015 May;51(7):852-60. doi: 10.1016/j.ejca.2015.02.015. Epub 2015 Mar 19.
10
Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.头颈部鳞状细胞癌患者的癌症特异性死亡率和竞争死亡率:一项竞争风险分析。
Ann Surg Oncol. 2015 Jan;22(1):264-71. doi: 10.1245/s10434-014-3951-8. Epub 2014 Jul 30.